Structural and micromechanical characterization of type I collagen gelsLATINOVIC, Olga; HOUGH, Lawrence A; OU-YANG, H. Daniel et al.Journal of biomechanics. 2010, Vol 43, Num 3, pp 500-505, issn 0021-9290, 6 p.Article

Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist MaravirocLATINOVIC, Olga; SCHNEIDER, Kate; SZMACINSKI, Henryk et al.Antiviral research. 2014, Vol 112, pp 80-90, issn 0166-3542, 11 p.Article

Rapamycin enhances aplaviroc anti-HIV activity: Implications for the clinical development of novel CCR5 antagonistsLATINOVIC, Olga; HEREDIA, Alonso; GALLO, Robert C et al.Antiviral research. 2009, Vol 83, Num 1, pp 86-89, issn 0166-3542, 4 p.Article

Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and preventionLATINOVIC, Olga; LE, Nhut; REITZ, Marvin et al.AIDS (London). 2011, Vol 25, Num 9, pp 1232-1235, issn 0269-9370, 4 p.Article

Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitroHEREDIA, Alonso; GILLIAM, Bruce; LATINOVIC, Olga et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 7, pp 2489-2496, issn 0066-4804, 8 p.Article